-
Konica Minolta Precision Medicine Announces Name Change to REALM IDx™
Read more: Konica Minolta Precision Medicine Announces Name Change to REALM IDx™(Aliso Viejo, CA) September 15, 2021 – Konica Minolta Precision Medicine (KMPM), a majority-owned subsidiary of Konica Minolta, Inc., announced today that it has changed its name to REALM IDx, Inc. The name change reflects the company’s focus in integrated diagnostics, an advanced field of clinical science that brings together genomics, radiology, pathology, and artificial…
-
KONICA MINOLTA PRECISION MEDICINE APPOINTS JONATHAN USUKA CHIEF STRATEGY & INFORMATICS OFFICER
Read more: KONICA MINOLTA PRECISION MEDICINE APPOINTS JONATHAN USUKA CHIEF STRATEGY & INFORMATICS OFFICER(Aliso Viejo, CA) August, 10, 2021 – Konica Minolta Precision Medicine (KMPM) announced today that Jonathan Usuka, Ph.D., has been appointed Chief Strategy and Informatics Officer, effective August 9, 2021. In this newly created role, Dr. Usuka will lead the corporation’s strategic roadmap and will be the driving force in identifying opportunities for KMPM to…
-
Ambry Genetics Named Best Company for Women and Workplace Culture
Read more: Ambry Genetics Named Best Company for Women and Workplace CultureComparably Ranks Ambry a Top Employer Out of 60,000 Companies Based on Employee High Ratings (Aliso Viejo, CA) December 16, 2020: Ambry Genetics Corporation (Ambry), a leading clinical diagnostic testing company, is proud to announce that they are the recipient of two Comparably Awards in recognition of the best companies for women and for providing…
-
Konica Minolta Precision Medicine, Inc. Acquires Backpack Health Assets
Read more: Konica Minolta Precision Medicine, Inc. Acquires Backpack Health AssetsAliso Viejo, CA (20 May 2020) – Konica Minolta Precision Medicine, Inc. (KMPM), a subsidiary of Konica Minolta, Inc. (Konica Minolta) today announced the acquisition of the assets of Backpack Health (BPH), a secure mobile and web-based health data management platform. The BPH tool empowers patients to securely store and manage their personal health information and…
-
First Prospective Study Shows +RNAinsight™ Identifies More Patients with Increased Risk for Hereditary Cancer Than DNA-Only Testing
Read more: First Prospective Study Shows +RNAinsight™ Identifies More Patients with Increased Risk for Hereditary Cancer Than DNA-Only TestingThe first notable improvement in diagnostic yield for high-risk cancer genes in more than 10 years, +RNAinsight adds RNA genetic testing to DNA multigene panels (Aliso Viejo, CA) February 25, 2020: Ambry Genetics (Ambry), a leading clinical genetic testing lab, announced the publication of a study in Nature Partner Journal Precision Oncology finding that RNA…
-
Invicro Scientists Work on Imaging Synaptic Density in Schizophrenia Published in Nature Communications
Read more: Invicro Scientists Work on Imaging Synaptic Density in Schizophrenia Published in Nature CommunicationsBOSTON, MA, 28 January 2020 – Invicro LLC, a Konica Minolta company announces that the paper “Synaptic Density Marker SV2A is Reduced in Schizophrenia Patients and Unaffected by Antipsychotics in Rats1” has been published in Nature Communications. Invicro is a global provider of imaging biomarkers, core lab services, advanced analytics and software solutions for drug…
-
Invicro and Paige Partner to Offer Comprehensive Tissue Biomarker Profiling Services
Read more: Invicro and Paige Partner to Offer Comprehensive Tissue Biomarker Profiling Services(BOSTON, MA and NEW YORK, NY) January 14, 2020 — Invicro LLC, a Konica Minolta Company and Paige, Inc., the leader in computational pathology, today announced a strategic alliance to provide integrated pathology solutions to support Pharmaceutical and Biotechnology sponsors with their drug discovery and development initiatives. Invicro is a global provider of imaging biomarkers, core lab services,…
-
Invicro LLC Announces Dr. Matthew Silva as New Chief Executive Officer and Dr. Jack Hoppin is Named President of Konica Minolta Precision Medicine
Read more: Invicro LLC Announces Dr. Matthew Silva as New Chief Executive Officer and Dr. Jack Hoppin is Named President of Konica Minolta Precision Medicine(BOSTON, MA) December 23, 2019 — Invicro LLC, a Konica Minolta company, today announces, Dr. Matthew Silva has been appointed as the new Chief Executive Officer. Dr. Silva will assume the day-to-day leadership responsibilities of the Company and will join Invicro’s Board of Directors, effective immediately. Dr. Jack Hoppin, co-founder of Invicro, will move on from…
-
Ambry Genetics Receives New York State Approval to Offer Paired RNA and DNA Genetic Testing for Hereditary Cancer Risk
Read more: Ambry Genetics Receives New York State Approval to Offer Paired RNA and DNA Genetic Testing for Hereditary Cancer Risk+RNAinsight™ is now available for New York patients, and will help identify thousands more patients at increased risk for cancer (Aliso Viejo, CA) December 16, 2019: Ambry Genetics® (Ambry), a leading clinical genetic testing company, announced today that the New York State Clinical Laboratory Evaluation Program (CLEP) has approved Ambry’s next-generation, paired RNA and DNA genetic…
-
New Data from Ambry Genetics Showed Concurrent RNA and DNA Testing Identified More Patients with Hereditary Breast Cancer than DNA Testing Alone
Read more: New Data from Ambry Genetics Showed Concurrent RNA and DNA Testing Identified More Patients with Hereditary Breast Cancer than DNA Testing AloneSeparate data demonstrated that finding mutations that increase risks for breast cancer frequently led clinicians to change their medical recommendations to patients. (Aliso Viejo, CA) December 10, 2019: Researchers at Ambry Genetics (Ambry), a leading clinical genetic testing lab, will announce new data showing that conducting RNA and DNA tests for hereditary cancer risk at…